financetom
Business
financetom
/
Business
/
Cintas Lifts Full-Year Outlook as Fiscal First-Quarter Results Beat Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas Lifts Full-Year Outlook as Fiscal First-Quarter Results Beat Estimates
Sep 25, 2024 7:59 AM

10:40 AM EDT, 09/25/2024 (MT Newswires) -- Cintas ( CTAS ) raised its full-year guidance on Wednesday as the uniform supplier reported stronger-than-expected fiscal first-quarter results.

The company now anticipates per-share earnings to come in between $4.17 and $4.25 for fiscal 2025, up from its initial outlook of $4.06 to $4.19. Revenue is pegged at $10.22 billion to $10.32 billion, compared with the prior forecast range of $10.16 billion to $10.31 billion.

The current consensus among analysts surveyed by Capital IQ is for EPS of $4.17 on revenue of $10.28 billion for the ongoing fiscal year. The stock edged up 1% in Wednesday trading.

"Our raised fiscal 2025 outlook reflects the continued momentum we see across the business," Chief Executive Todd Schneider said in a statement.

For the three months through August, earnings advanced 18% year over year to $1.10 a share, topping the Street's view for $1. Revenue rose to $2.5 billion from $2.34 billion a year earlier, just ahead of analysts' $2.49 billion estimate.

Sales from uniform rental and facility services grew 5.9% to $1.93 billion, while other revenue increased to $567.7 million from $515.5 million.

Gross margin as a percentage of revenue improved 140 basis points year over year to 50.1% in the first quarter. Selling and administrative expenses rose to $691.1 million from $641 million last year, according to the company.

"Our first-quarter fiscal 2025 results reflect the strength and breadth of Cintas' ( CTAS ) value proposition for businesses of all types," Schneider said. "Cintas ( CTAS ) delivered revenue and earnings growth, continued margin expansion and strong cash generation, all of which enabled our balanced approach to capital allocation."

Price: 206.32, Change: +1.47, Percent Change: +0.72

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brookdale Senior Living's Momentum Seen to Continue After Q1 Revenue Per Unit Growth, RBC Says
Brookdale Senior Living's Momentum Seen to Continue After Q1 Revenue Per Unit Growth, RBC Says
May 14, 2024
12:55 PM EDT, 05/14/2024 (MT Newswires) -- Brookdale Senior Living's ( BKD ) momentum is expected to continue through the rest of 2024 following its Q1 results that were driven by solid growth in revenue per available unit, or RevPAR, and labor expense management, RBC Capital Markets said in a note. We are encouraged that management expects RevPAR growth to...
Avis Budget Group Unit Prices Notes Offering
Avis Budget Group Unit Prices Notes Offering
May 14, 2024
12:59 PM EDT, 05/14/2024 (MT Newswires) -- Avis Budget Group ( CAR ) said Tuesday its Avis Budget Finance unit priced a private offering of 200 million euros ($216.4 million) of additional 7.25% senior notes due July 31, 2030, at 100.25% of their face value. The unit previously issued 400 million euros of the notes under a July 2023 indenture,...
BRIEF-Healthcare-Payments Company Waystar Is Eyeing An Initial Public Offering In Early June- WSJ
BRIEF-Healthcare-Payments Company Waystar Is Eyeing An Initial Public Offering In Early June- WSJ
May 14, 2024
May 14 (Reuters) - * HEALTHCARE-PAYMENTS COMPANY WAYSTAR IS EYEING AN INITIAL PUBLIC OFFERING IN EARLY JUNE- WSJ Source text: https://tinyurl.com/ycnbxfat Further company coverage: [ ] ...
NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield
NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield
May 14, 2024
12:55 PM EDT, 05/14/2024 (MT Newswires) -- NanoVibronix ( NAOV ) said Tuesday that it has signed a multiyear agreement with CB Medical to sell and distribute the company's UroShield ultrasound-based product. Financial terms were not disclosed. Under the terms of the agreement, CB Medical has the right to sell and distribute UroShield to its customers through the US Department...
Copyright 2023-2026 - www.financetom.com All Rights Reserved